Artificial Saliva Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research has recently released a comprehensive report on the global Artificial Saliva Market. This report provides an in-depth analysis of key market dynamics such as drivers, trends, opportunities, and challenges, offering detailed insights into the market structure. The publication presents exclusive data and statistics outlining the projected growth trajectory of the global artificial saliva market from 2024 to 2031.

Key Insights:

Artificial Saliva Market Size (2024E): USD 1.8 Billion
Projected Market Value (2031F): USD 10.2 Billion
Global Market Growth Rate (CAGR 2024 to 2031): 28.1%

Artificial Saliva Market - Report Scope:

Artificial saliva plays a critical role in the management of dry mouth (xerostomia), a condition often resulting from various factors such as medication side effects, chemotherapy, and certain health conditions. The market serves individuals with this condition, offering solutions like oral sprays, gels, and rinses to help alleviate symptoms and improve quality of life. Growing awareness about dry mouth, rising geriatric populations, and increasing incidence of chronic diseases are driving the growth of the artificial saliva market.

Market Growth Drivers:

Several factors are propelling the growth of the artificial saliva market. The increasing prevalence of dry mouth due to rising cases of Sjogren's syndrome, diabetes, and cancer treatments is a significant driver. Additionally, the aging global population, which is more susceptible to xerostomia, contributes to market expansion. The increasing awareness about the availability of artificial saliva products and the growing preference for non-prescription solutions are also contributing factors. Furthermore, technological advancements in the formulation of artificial saliva products, such as improved taste and long-lasting moisture, are enhancing market growth.

Market Restraints:

Despite the promising growth trajectory, the artificial saliva market faces several challenges. One of the primary restraints is the high cost of some advanced artificial saliva products, making them less accessible to a broader population. Additionally, the limited awareness about the various forms of treatment, especially in underdeveloped regions, hampers market penetration. The availability of alternative treatments, such as mouthwashes and medications, also poses a challenge to the widespread adoption of artificial saliva products.

Market Opportunities:

The artificial saliva market presents significant opportunities driven by innovations in product development and expanding healthcare access. The growing focus on oral health and wellness, along with increased research into natural-based saliva substitutes, is creating new avenues for market players. Additionally, the rise in demand for oral care products among aging populations and cancer patients undergoing chemotherapy presents an opportunity for growth. Strategic partnerships, technological innovations, and the development of cost-effective products are key to tapping into these opportunities.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the artificial saliva market globally?
What are the most common types of artificial saliva products in demand, and how do they vary in application?
How is the increasing geriatric population influencing the market for artificial saliva?
Who are the key players in the artificial saliva market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global artificial saliva market?

Competitive Intelligence and Business Strategy:

Leading players in the artificial saliva market, including companies like Colgate-Palmolive, GlaxoSmithKline, and Johnson & Johnson, are focusing on product innovation, regulatory compliance, and strategic partnerships to strengthen their market positions. These companies are investing in research and development to improve the efficacy and consumer experience of artificial saliva products. Collaborations with healthcare providers and pharmaceutical companies are helping to enhance the reach and availability of these products in the global market. Additionally, companies are focusing on consumer education to increase awareness and encourage the adoption of artificial saliva solutions.

Key Companies Profiled:

GlaxoSmithKline plc
Cipla Limited
Mission Pharmacal Company
Fresenius Kabi
Parnell Pharmaceuticals, Inc.
CCMed Group
Entod International
Midatech Pharma Plc.
Forward Science
Valeant Pharmaceuticals International, Inc.
Biocosmetics Laboratories
Icpa Health Products LTD.
Perrigo
Laboratorios Kin, S.A.

Artificial Saliva Market Taxonomy

Product Type

Oral Spray
Oral Solution
Oral Liquid
Gel
Powder

Age Group

Adult
Paediatric

Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Hypermarkets and Supermarkets

Region

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Product Code: PMRREP16891

1. Executive Summary

1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Definition
2.2. Market Taxonomy

3. Artificial Saliva Market Opportunity Analysis

3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. North America Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033

4.1. Introduction
4.2. Regional Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Trends
4.3. Historical Market Size (US$ Bn) and Trend Analysis By Country, 2019-2023
- 4.3.1. U.S.
- 4.3.2. Canada
4.4. Market Size (US$ Bn) and Forecast By Country, 2024-2033
- 4.4.1. U.S.
- 4.4.2. Canada
4.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019-2023
- 4.5.1. Oral Spray
- 4.5.2. Oral Solution
- 4.5.3. Oral Liquid
- 4.5.4. Gel
- 4.5.5. Powder
4.6. Market Size (US$ Bn) and Forecast By Product Type, 2024-2033
- 4.6.1. Oral Spray
- 4.6.2. Oral Solution
- 4.6.3. Oral Liquid
- 4.6.4. Gel
- 4.6.5. Powder
4.7. Historical Market Size (US$ Bn) Trend Analysis By Age-Group, 2019-2023
- 4.7.1. Adult
- 4.7.2. Pediatric
4.8. Market Size (US$ Bn) and Forecast By Age-Group, 2024-2033
- 4.8.1. Adult
- 4.8.2. Pediatric
4.9. Historical Market Size (US$ Bn) and Trend Analysis By Distribution Channel, 2019-2023
- 4.9.1. Hospital Pharmacies
- 4.9.2. Retail Pharmacies
- 4.9.3. Mail Order Pharmacies
- 4.9.4. Hypermarkets and Supermarkets
4.10. Market Size (US$ Bn) and Forecast By Distribution Channel, 2024-2033
- 4.10.1. Hospital Pharmacies
- 4.10.2. Retail Pharmacies
- 4.10.3. Mail Order Pharmacies
- 4.10.4. Hypermarkets and Supermarkets
4.11. Drivers and Restraints: Impact Analysis
4.12. Market Attractiveness Analysis
- 4.12.1. By Country
- 4.12.2. By Product Type
- 4.12.3. By Age-Group
- 4.12.4. By Distribution Channel
4.13. Key Representative Market Participants
4.14. Market Presence (Intensity Map)

5. Latin America Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033

5.1. Introduction
5.2. Regional Market Dynamics
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Trends
5.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2019-2023
- 5.3.1. Brazil
- 5.3.2. Mexico
- 5.3.3. Rest of Latin America
5.4. Market Size (US$ Bn) and Forecast By Country, 2024-2033
- 5.4.1. Brazil
- 5.4.2. Mexico
- 5.4.3. Rest of Latin America
5.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019-2023
- 5.5.1. Oral Spray
- 5.5.2. Oral Solution
- 5.5.3. Oral Liquid
- 5.5.4. Gel
- 5.5.5. Powder
5.6. Market Size (US$ Bn) and Forecast By Product Type, 2024-2033
- 5.6.1. Oral Spray
- 5.6.2. Oral Solution
- 5.6.3. Oral Liquid
- 5.6.4. Gel
- 5.6.5. Powder
5.7. Historical Market Size (US$ Bn) Trend Analysis By Age-Group, 2019-2023
- 5.7.1. Adult
- 5.7.2. Pediatric
5.8. Market Size (US$ Bn) and Forecast By Age-Group, 2024-2033
- 5.8.1. Adult
- 5.8.2. Pediatric
5.9. Historical Market Size (US$ Bn) and Trend Analysis By Distribution Channel, 2019-2023
- 5.9.1. Hospital Pharmacies
- 5.9.2. Retail Pharmacies
- 5.9.3. Mail Order Pharmacies
- 5.9.4. Hypermarkets and Supermarkets
5.10. Market Size (US$ Bn) and Forecast By Distribution Channel, 2024-2033
- 5.10.1. Hospital Pharmacies
- 5.10.2. Retail Pharmacies
- 5.10.3. Mail Order Pharmacies
- 5.10.4. Hypermarkets and Supermarkets
5.11. Drivers and Restraints: Impact Analysis
5.12. Market Attractiveness Analysis
- 5.12.1. By Country
- 5.12.2. By Product Type
- 5.12.3. By Age-Group
- 5.12.4. By Distribution Channel
5.13. Key Representative Market Participants
5.14. Market Presence (Intensity Map)

6. Europe Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033

6.1. Introduction
6.2. Regional Market Dynamics
- 6.2.1. Drivers
- 6.2.2. Restraints
- 6.2.3. Trends
6.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2019-2023
- 6.3.1. Germany
- 6.3.2. U.K.
- 6.3.3. France
- 6.3.4. Italy
- 6.3.5. Spain
- 6.3.6. Russia
- 6.3.7. Rest of Europe
6.4. Market Size (US$ Bn) and Forecast By Country, 2024-2033
- 6.4.1. Germany
- 6.4.2. U.K.
- 6.4.3. France
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Rest of Europe
6.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019-2023
- 6.5.1. Oral Spray
- 6.5.2. Oral Solution
- 6.5.3. Oral Liquid
- 6.5.4. Gel
- 6.5.5. Powder
6.6. Market Size (US$ Bn) and Forecast By Product Type, 2024-2033
- 6.6.1. Oral Spray
- 6.6.2. Oral Solution
- 6.6.3. Oral Liquid
- 6.6.4. Gel
- 6.6.5. Powder
6.7. Historical Market Size (US$ Bn) Trend Analysis By Age-Group, 2019-2023
- 6.7.1. Adult
- 6.7.2. Pediatric
6.8. Market Size (US$ Bn) and Forecast By Age-Group, 2024-2033
- 6.8.1. Adult
- 6.8.2. Pediatric
6.9. Historical Market Size (US$ Bn) and Trend Analysis By Distribution Channel, 2019-2023
- 6.9.1. Hospital Pharmacies
- 6.9.2. Retail Pharmacies
- 6.9.3. Mail Order Pharmacies
- 6.9.4. Hypermarkets and Supermarkets
6.10. Market Size (US$ Bn) and Forecast By Distribution Channel, 2024-2033
- 6.10.1. Hospital Pharmacies
- 6.10.2. Retail Pharmacies
- 6.10.3. Mail Order Pharmacies
- 6.10.4. Hypermarkets and Supermarkets
6.11. Drivers and Restraints: Impact Analysis
6.12. Market Attractiveness Analysis
- 6.12.1. By Country
- 6.12.2. By Product Type
- 6.12.3. By Age-Group
- 6.12.4. By Distribution Channel
6.13. Key Representative Market Participants
6.14. Market Presence (Intensity Map)

7. Asia Pacific Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033

7.1. Introduction
7.2. Regional Market Dynamics
- 7.2.1. Drivers
- 7.2.2. Restraints
- 7.2.3. Trends
7.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2019-2023
- 7.3.1. China
- 7.3.2. Japan
- 7.3.3. India
- 7.3.4. ASEAN
- 7.3.5. Australia and New Zealand
- 7.3.6. Rest of Asia Pacific
7.4. Market Size (US$ Bn) and Forecast By Country, 2024-2033
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. India
- 7.4.4. ASEAN
- 7.4.5. Australia and New Zealand
- 7.4.6. Rest of Asia Pacific
7.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019-2023
- 7.5.1. Oral Spray
- 7.5.2. Oral Solution
- 7.5.3. Oral Liquid
- 7.5.4. Gel
- 7.5.5. Powder
7.6. Market Size (US$ Bn) and Forecast By Product Type, 2024-2033
- 7.6.1. Oral Spray
- 7.6.2. Oral Solution
- 7.6.3. Oral Liquid
- 7.6.4. Gel
- 7.6.5. Powder
7.7. Historical Market Size (US$ Bn) Trend Analysis By Age-Group, 2019-2023
- 7.7.1. Adult
- 7.7.2. Pediatric
7.8. Market Size (US$ Bn) and Forecast By Age-Group, 2024-2033
- 7.8.1. Adult
- 7.8.2. Pediatric
7.9. Historical Market Size (US$ Bn) and Trend Analysis By Distribution Channel, 2019-2023
- 7.9.1. Hospital Pharmacies
- 7.9.2. Retail Pharmacies
- 7.9.3. Mail Order Pharmacies
- 7.9.4. Hypermarkets and Supermarkets
7.10. Market Size (US$ Bn) and Forecast By Distribution Channel, 2024-2033
- 7.10.1. Hospital Pharmacies
- 7.10.2. Retail Pharmacies
- 7.10.3. Mail Order Pharmacies
- 7.10.4. Hypermarkets and Supermarkets
7.11. Drivers and Restraints: Impact Analysis
7.12. Market Attractiveness Analysis
- 7.12.1. By Country
- 7.12.2. By Product Type
- 7.12.3. By Age-Group
- 7.12.4. By Distribution Channel
7.13. Key Representative Market Participants
7.14. Market Presence (Intensity Map)

8. Middle East & Africa Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033

8.1. Introduction
8.2. Regional Market Dynamics
- 8.2.1. Drivers
- 8.2.2. Restraints
- 8.2.3. Trends
8.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2019-2023
- 8.3.1. GCC Countries
- 8.3.2. South Africa
- 8.3.3. Rest of MEA
8.4. Market Size (US$ Bn) and Forecast By Country, 2024-2033
- 8.4.1. GCC Countries
- 8.4.2. South Africa
- 8.4.3. Rest of MEA
8.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019-2023
- 8.5.1. Oral Spray
- 8.5.2. Oral Solution
- 8.5.3. Oral Liquid
- 8.5.4. Gel
- 8.5.5. Powder
8.6. Market Size (US$ Bn) and Forecast By Product Type, 2024-2033
- 8.6.1. Oral Spray
- 8.6.2. Oral Solution
- 8.6.3. Oral Liquid
- 8.6.4. Gel
- 8.6.5. Powder
8.7. Historical Market Size (US$ Bn) Trend Analysis By Age-Group, 2019-2023
- 8.7.1. Adult
- 8.7.2. Pediatric
8.8. Market Size (US$ Bn) and Forecast By Age-Group, 2024-2033
- 8.8.1. Adult
- 8.8.2. Pediatric
8.9. Historical Market Size (US$ Bn) and Trend Analysis By Distribution Channel, 2019-2023
- 8.9.1. Hospital Pharmacies
- 8.9.2. Retail Pharmacies
- 8.9.3. Mail Order Pharmacies
- 8.9.4. Hypermarkets and Supermarkets
8.10. Market Size (US$ Bn) and Forecast By Distribution Channel, 2024-2033
- 8.10.1. Hospital Pharmacies
- 8.10.2. Retail Pharmacies
- 8.10.3. Mail Order Pharmacies
- 8.10.4. Hypermarkets and Supermarkets
8.11. Drivers and Restraints: Impact Analysis
8.12. Market Attractiveness Analysis
- 8.12.1. By Country
- 8.12.2. By Product Type
- 8.12.3. By Age-Group
- 8.12.4. By Distribution Channel
8.13. Key Representative Market Participants
8.14. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape

11.1. Competition Dashboard
11.2. Market Structure
11.3. Company Profiles (Details - Overview, Financials, Strategy, SWOT, Recent Developments)
- 11.3.1. GlaxoSmithKline plc
- 11.3.2. Cipla Limited
- 11.3.3. Mission Pharmacal Company
- 11.3.4. Fresenius Kabi
- 11.3.5. Parnell Pharmaceuticals, Inc.
- 11.3.6. CCMed Group
- 11.3.7. Entod International
- 11.3.8. Midatech Pharma Plc.
- 11.3.9. Forward Science
- 11.3.10. Valeant Pharmaceuticals International, Inc.
- 11.3.11. Biocosmetics Laboratories
- 11.3.12. Icpa Health Products LTD.
- 11.3.13. Perrigo
- 11.3.14. Laboratorios Kin, S.A.

12. Global Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033, By Region

12.1. Introduction/Key Findings
12.2. Historical Market Size (US$ Bn) Trend Analysis By Region, 2019-2023
- 12.2.1. North America
- 12.2.2. Latin America
- 12.2.3. Europe
- 12.2.4. Asia Pacific
- 12.2.5. Middle East & Africa
12.3. Market Size (US$ Bn) and Forecast By Region, 2024-2033
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. Asia Pacific
- 12.3.5. Middle East & Africa
12.4. Market Attractiveness Analysis By Region

13. Global Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033, By Product Type

13.1. Introduction/Key Findings
13.2. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019-2023
- 13.2.1. Oral Spray
- 13.2.2. Oral Solution
- 13.2.3. Oral Liquid
- 13.2.4. Gel
- 13.2.5. Powder
13.3. Market Size (US$ Bn) and Forecast By Product Type, 2024-2033
- 13.3.1. Oral Spray
- 13.3.2. Oral Solution
- 13.3.3. Oral Liquid
- 13.3.4. Gel
- 13.3.5. Powder
13.4. Market Attractiveness Analysis By Product Type

14. Global Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033, By Age-Group

14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Bn) Trend Analysis By Age-Group, 2019-2023
- 14.2.1. Adult
- 14.2.2. Pediatric
14.3. Market Size (US$ Bn) and Forecast By Age-Group, 2024-2033
- 14.3.1. Adult
- 14.3.2. Pediatric
14.4. Market Attractiveness Analysis By Age-Group

15. Global Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

Assessment of distribution channel currently gaining traction in the artificial saliva field

15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Bn) Trend Analysis By Distribution Channel, 2019-2023
- 15.2.1. Hospital Pharmacies
- 15.2.2. Retail Pharmacies
- 15.2.3. Mail Order Pharmacies
- 15.2.4. Hypermarkets and Supermarkets
15.3. Market Size (US$ Bn) and Forecast By Distribution Channel, 2024-2033
- 15.3.1. Hospital Pharmacies
- 15.3.2. Retail Pharmacies
- 15.3.3. Mail Order Pharmacies
- 15.3.4. Hypermarkets and Supermarkets
15.4. Market Attractiveness Analysis By Distribution Channel

16. Global Artificial Saliva Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Market Size and Y-o-Y Growth
16.2. Absolute $ Opportunity